Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced ...
AstraZeneca has begun a new agreement with Daiichi Sankyo to develop and market an antibody to treat cancer, worth up to $6 billion. The deal covers DS-1062, Daiichi Sankyo’s proprietary antibody-drug ...
The Denver Broncos won one of the most exciting games in recent NFL memory in Week 7, overcoming an 18-point deficit to defeat the New York Giants 33-32. The Broncos scored all 33 points in the fourth ...
VANCOUVER, British Columbia & DALLAS, July 01, 2025--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG) ("Alpha Cognition" [ACI], or the "Company"), a biopharmaceutical company developing novel ...
VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG) (CSE: ACOG) (“Alpha Cognition” [ACI], or the “Company”), a ...
In database management, it’s easy to assume that newer technologies are always better. While many database solutions have gained popularity in recent years, MySQL—one of the oldest and most widely ...
On July 29, 2024, the U.S. FDA approved Alpha Cognition Inc.'s ALPHA-1062 (Zunveyl ®), an Acetylcholinesterase (AChE) inhibitor, for treating mild-to-moderate Alzheimer’s disease. This condition ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
Wordle 1062 puzzle, created by Brooklyn-based software engineer Josh Wardle, gained popularity among global users for its daily challenges testing linguistic skills. Today's word is STALL. Wordle 1062 ...
Forbes contributors publish independent expert analyses and insights. I write about TV shows, movies, video games, entertainment & culture. Looking for Wednesday’s Wordle hints, clues and answer? You ...
The investigational agent was designed to reduce the gastrointestinal side effects observed with galantamine. The Food and Drug Administration (FDA) has accepted for review the New Drug Application ...
The Board of Directors of DSV A/S announces changes to the Executive Board. Effective 30 September 2024, Group CEO Jens Bjørn Andersen will step down after 16 years in charge of the DSV Group. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback